Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.
The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most receiving PCI, according to an analysis presented this week at CRT 2026. But as ...
Ami Bhatt speaks to Henri Justino about strategies to support right ventricular growth, PA/IVS, and where current advancements can take us in the future.